RollingStone Co EV/FCF

Que fait RollingStone Co ? MiCo BioMed Co. Ltd. generates revenue through three business segments. The Molecular Diagnosis segment sells nucleic acid extraction equipment, gene amplification equipment, reagents, and lab chips. The Biochemical Diagnosis segment supplies complex diagnostics, anemia meters, blood glucose meters, medical devices, and strips. The Immunodiagnostic Business segment produces and sells immunodiagnostic devices and immunodiagnostic kits. These products are sold to healthcare providers and medical facilities that require diagnostic tools for patient testing and analysis. The company's products target healthcare institutions including hospitals and clinics. Medical professionals use these devices for accurate diagnosis and treatment planning. The Biochemical Diagnosis segment's blood glucose meters and anemia meters are particularly used in point-of-care testing environments. The Molecular Diagnosis segment's gene amplification equipment supports laboratory-based genetic testing procedures. MiCo BioMed's business model focuses on direct sales to medical institutions and healthcare providers. The company does not mention any third-party distributors or online sales channels. Its product portfolio serves both hospital laboratories and outpatient diagnostic centers. The Immunodiagnostic Business segment's kits are designed for rapid testing applications in clinical settings. RollingStone Co est l'une des entreprises les plus populaires sur Eulerpool.